TY - JOUR
T1 - Cutting edge
T2 - Synchronization of IRF1, JunB, and C/EBPβ activities during TLR3-TLR7 cross-talk orchestrates timely cytokine synergy in the proinflammatory response
AU - Liu, Qian
AU - Zhu, Yong
AU - Yong, Wai Khang
AU - Sze, Newman Siu Kwan
AU - Tan, Nguan Soon
AU - Ding, Jeak Ling
N1 - Publisher Copyright:
Copyright © 2015 by The American Association of Immunologists, Inc.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Multiple pathogen-Associated molecular pattern-induced TLR pathway cross-talk provokes proinflammatory cytokine synergy in macrophages, which is important for pathogen resistance and immune homeostasis. However, the detailed mechanisms are unclear. In this article, we demonstrate viral RNA analog-induced transcription synergy of Il6 and Il12b via IFN regulatory factor (IRF)1 (TLR3-TIR domain-containing adaptor inducing IFN-β [TRIF] responsive), C/EBPβ (TLR7-MyD88 responsive), and JunB (all responsive). Coactivation of the TLR3 and TLR7 pathways synchronizes the interaction of IRF1, JunB, and C/EBPβ with the Il6 and Il12b promoters, facilitating maximal gene expression. MyD88 pathway activation suppresses TRIFinduced IRF1 in a delayed manner, controlling the magnitude and timing of cytokine expression. Our findings provide novel mechanisms of cooperation of different TLR pathways to achieve optimal immune responses, with the potential for immunomodulatory strategies.
AB - Multiple pathogen-Associated molecular pattern-induced TLR pathway cross-talk provokes proinflammatory cytokine synergy in macrophages, which is important for pathogen resistance and immune homeostasis. However, the detailed mechanisms are unclear. In this article, we demonstrate viral RNA analog-induced transcription synergy of Il6 and Il12b via IFN regulatory factor (IRF)1 (TLR3-TIR domain-containing adaptor inducing IFN-β [TRIF] responsive), C/EBPβ (TLR7-MyD88 responsive), and JunB (all responsive). Coactivation of the TLR3 and TLR7 pathways synchronizes the interaction of IRF1, JunB, and C/EBPβ with the Il6 and Il12b promoters, facilitating maximal gene expression. MyD88 pathway activation suppresses TRIFinduced IRF1 in a delayed manner, controlling the magnitude and timing of cytokine expression. Our findings provide novel mechanisms of cooperation of different TLR pathways to achieve optimal immune responses, with the potential for immunomodulatory strategies.
UR - http://www.scopus.com/inward/record.url?scp=84937717318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937717318&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1402358
DO - 10.4049/jimmunol.1402358
M3 - Article
C2 - 26109639
AN - SCOPUS:84937717318
SN - 0022-1767
VL - 195
SP - 801
EP - 805
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -